FBLG vs PNC · $24.0M cap vs P/E 14, rev $6.88B
FibroBiologics, Inc. Common Stock (FBLG) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on US.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
FBLG does not have a complete income-statement cache yet.
Latest reported PNC revenue for 2026-06-30 was $6.88B. Net income was $2.04B. Revenue was up 11.5% from 2026-03-31 to 2026-06-30. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
FBLG currently screens at market cap $24.0M. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the FBLG and PNC stock pages for the full models.
Not investment advice.